Skip to main content
Published locations for Ramucirumab effective in patients with advanced HCC and AFP ≥400 ng/mL after non-sorafenib therapies
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Ramucirumab effective in patients with advanced HCC and AFP ≥400 ng/mL after non-sorafenib therapies
User login
Username
Password
Reset your password
/content/ramucirumab-effective-patients-advanced-hcc-and-afp-400-ng/ml-after-non-sorafenib-0
/gihepnews/article/258882/hepatocellular-carcinoma/ramucirumab-effective-patients-advanced-hcc-and